NEW YORK (GenomeWeb News) – GVK Biosciences today said that it has partnered with the Indiana Clinical and Translational Sciences Institute to provide researchers across the US with access to GVK's Clinical Biomarker Database.
According to GVK, the Indiana CTSI Bioinformatics Core and the Indiana Institute for Personalized Medicine will work together to manage the process by which researchers can access the new resource. The database, also known as GOBIOM, is a "comprehensive collection" of biomarkers associated with a variety of therapeutic areas reported in global clinical trials, as well as clinical and preclinical studies.
GOBIOM will be available to researchers at 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health.
Hyderabad, India-based GVK noted that the agreement was facilitated by the Indiana Economic Development Corporation during a February economic mission to India.